Kasendorf, Germany

Juergen Soutschek

USPTO Granted Patents = 10 

 


Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Sulgen, CH (2010 - 2013)
  • Kasendorf, DE (2009 - 2015)
  • Sulgen, DE (2015)

Company Filing History:


Years Active: 2009-2015

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Sure, here is the article about inventor Juergen Soutschek:

Title: Innovator Spotlight: Juergen Soutschek - Pioneering RNAi Therapeutics

Introduction:

Juergen Soutschek, a distinguished inventor based in Kasendorf, Germany, has made significant contributions to the field of RNA interference (RNAi) therapeutics. With a remarkable portfolio of 10 patents to his name, Juergen has been at the forefront of developing innovative methods for gene modulation and treatment of genetic disorders.

Latest Patents:

1. "RNAi modulation of ApoB and uses thereof": This patent centers around compositions and techniques for downregulating apolipoprotein B using chemically modified oligonucleotides, showcasing Juergen's expertise in RNAi technology.

2. "RNAi modulation of SCAP and therapeutic uses thereof": Introducing a novel approach to inhibiting SCAP gene expression, this patent illustrates Juergen's commitment to advancing therapeutics for diseases associated with SCAP gene expression.

Career Highlights:

Juergen Soutschek has left an indelible mark on the industry through his work with renowned organizations such as Alnylam Pharmaceuticals, Inc. and the University of Texas System. His pioneering research has led to groundbreaking advancements in the field of RNAi therapeutics, positioning him as a key figure in the realm of genetic medicine.

Collaborations:

During his career, Juergen has had the privilege of collaborating with esteemed professionals in the field, including Hans-Peter Vornlocher and Philipp Hadwiger. Their collective expertise has paved the way for innovative solutions in gene modulation and therapeutic interventions.

Conclusion:

In conclusion, Juergen Soutschek's innovative spirit and dedication to advancing RNAi therapeutics have established him as a trailblazer in the realm of genetic medicine. His groundbreaking patents and collaborations underscore his commitment to driving progress in the field, offering hope for the development of novel treatment modalities for genetic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…